Details for New Drug Application (NDA): 018279

NDA 018279 describes K-TAB, which is a drug marketed by Abbvie and is included in one NDA. Additional details are available on the K-TAB profile page.

The generic ingredient in K-TAB is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.

Summary for 018279

Tradename:	K-TAB
Applicant:	Abbvie
Ingredient:	potassium chloride
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	10MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	8MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:	Aug 1, 1988	TE:		RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	20MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:	Nov 25, 2013	TE:		RLD:	Yes

Complete Access Available with Subscription